Kristin Abate - 21 Jan 2026 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Chief Accounting Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Kristin Abate
Issuer symbol
KPTI
Transactions as of
21 Jan 2026
Net transactions value
-$1,579
Form type
4
Filing time
22 Jan 2026, 16:09:23 UTC
Previous filing
16 Oct 2025
Next filing
29 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Abate Kristin Chief Accounting Officer C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, NEWTON /s/ Nancy Smith as Attorney-in-Fact for Kristin Abate 22 Jan 2026 0002045943

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $1,579 -265 -1.2% $5.96 22,580 21 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.